Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Marfan Syndrome and CYP2C9[original query] |
---|
Genetic and clinical determinants influencing warfarin dosing in children with heart disease. Pediatric cardiology 2012 Nov . Nguyen N, Anley P, Yu MY, Zhang G, Thompson AA, Jennings LJ |
Pharmacogenetic approach to losartan in Marfan patients: a starting point to improve dosing regimen? Drug metabolism and personalized therapy 2016 Jul . Falvella Felicia Stefania, Marelli Susan, Cheli Stefania, Montanelli Stefano, Viecca Federico, Salvi Lucia, Ferrara Alfio, Clementi Emilio, Trifirò Giuliana, Pini Alessand |
Variants in ADRB1 and CYP2C9: Association with Response to Atenolol and Losartan in Marfan Syndrome. The Journal of pediatrics 2020 6 222 213-220.e5. Van Driest Sara L, Sleeper Lynn A, Gelb Bruce D, Morris Shaine A, Dietz Harry C, Forbus Geoffrey A, Goldmuntz Elizabeth, Hoskoppal Arvind, James Jeanne, Lee Teresa M, Levine Jami C, Li Jennifer S, Loeys Bart L, Markham Larry W, Meester Josephina A N, Mital Seema, Mosley Jonathan D, Olson Aaron K, Renard Marjolijn, Shaffer Christian M, Sharkey Angela, Young Luciana, Lacro Ronald V, Roden Dan |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: